- By Jeff Olsen
Mayo Clinic Minute: Blood-based lung cancer test shows promise
"We were very pleased to see those results," says Dr. David Ahlquist, a Mayo Clinic gastroenterologist who previously worked with Exact Sciences to develop a colon cancer test called Cologuard. "This new test approach that targets novel DNA markers had a sensitivity of 96 percent for lung cancer detection at 94 percent specificity."
Doctors say further research is needed, but the test shows promise for becoming a valuable new tool in the fight against lung cancer, the No. 1 cancer killer in the U.S.
In this Mayo Clinic Minute, Drs. Ahlquist and Midthun explain how the test works and why it has the potential to change the way you’re screened for lung cancer. Jeff Olsen reports.
Hear more from the doctors:
- Dr. Midthun discusses the prevalence of lung cancer in the U.S.
- Dr. Ahlquist explains the findings of the lung cancer blood test study.
- Dr. David Midthun discusses what the prototype lung cancer blood test means for the future.
- Dr. David Midthun explains how a blood-based lung cancer test could reduce concern and additional procedures.
Journalists: Broadcast-quality video is in the downloads. Read the Mayo Clinic Minute script (1:00).